Effect of Finerenone on Albuminuria in Type 1 Diabetes by Baseline HbA1c Level and Diabetes Duration: An Exploratory Analysis of the FINE-ONE Trial.
Saved in:
| Title: | Effect of Finerenone on Albuminuria in Type 1 Diabetes by Baseline HbA1c Level and Diabetes Duration: An Exploratory Analysis of the FINE-ONE Trial. |
|---|---|
| Authors: | Beernink JM; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; The George Institute for Global Health, University of New South Wales, Sydney, Australia., Birkenfeld AL; Institute for Diabetes Research and Metabolic Diseases, Helmholtz Centre Munich, University of Tübingen, Tübingen, Germany.; German Center for Diabetes Research, Neuherberg, Germany.; Internal Medicine IV, Department of Endocrinology, Diabetology and Nephrology, University of Tübingen, Tübingen, Germany., Cherney DZI; Division of Nephrology, University Health Network, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada., Colhoun HM; Institute of Genetics and Cancer, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, U.K., Groop PH; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Ji L; Department of Endocrinology and Metabolism, Peking University People's Hospital, Peking University Diabetes Center, Beijing, China., Mathieu C; Clinical and Experimental Endocrinology, KU Leuven, Leuven, Belgium., Rosas SE; Kidney and Hypertension Unit, Joslin Diabetes Center and Harvard Medical School, Boston, MA., Tuttle KR; Providence Inland Northwest Health, University of Washington School of Medicine, Spokane, WA., Skyler JS; Department of Medicine and Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL., Amor AJ; Diabetes Unit, Endocrinology and Nutrition Department, Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, Madrid, Spain., Caramori ML; Department of Endocrinology and Metabolism, Institute of Clinical Sciences, Cleveland Clinic Foundation, Cleveland, OH., Fiorina P; Division of Endocrinology, ASST Fatebenefratelli-Sacco and Universita degli Studi di Milano, Milan, Italy., Jongs N; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Pagotto U; Division of Endocrinology and Diabetes Prevention and Care, IRCCS Policlinico Sant'Orsola and Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Clinical and Surgical Sciences, University of Bologna, Bologna, Italy., Setola E; Cardio-metabolic and Clinical Trials Unit, IRCCS San Raffaele Hospital Scientific Institute, Milan, Italy., Brinker M; Cardiology and Nephrology Clinical Development, Bayer AG, Wuppertal, Germany., Lawatscheck R; Cardiology and Nephrology Clinical Development, Bayer AG, Berlin, Germany., Russel J; Bayer PLC, Reading, U.K., Schloemer P; Clinical Statistics & Analytics, Bayer AG, Berlin, Germany., McGill JB; Division of Endocrinology, Metabolism & Lipid Research, Washington University School of Medicine in St. Louis, St. Louis, MO., Rossing P; Steno Diabetes Center Copenhagen, Herlev, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. |
| Corporate Authors: | FINE-ONE investigators* |
| Source: | Diabetes care [Diabetes Care] 2026 Aug 01; Vol. 49 (8), pp. 1434-1441. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1935-5548 |
|---|---|
| DOI: | 10.2337/dc26-0882 |
